"non metastatic cancer" trang 3 - tải miễn phí từ tailieuXANH
A non-controlled, single arm, open label, phase II study of intravenous and intratumoral administration of ParvOryx in patients with metastatic, inoperable pancreatic cancer: ParvOryx02 protocol

A non-controlled, single arm, open label, phase II study of intravenous and intratumoral administration of ParvOryx in patients with metastatic, inoperable pancreatic cancer: ParvOryx02 protocol
11    89    0
Prospective study of oncologic outcomes after laparoscopic modified complete mesocolic excision for non-metastatic right colon cancer (PIONEER study): Study protocol of a multicentre single-arm trial

Prospective study of oncologic outcomes after laparoscopic modified complete mesocolic excision for non-metastatic right colon cancer (PIONEER study): Study protocol of a multicentre single-arm trial
10    138    0
Log odds of positive lymph nodes is prognostically equivalent to lymph node ratio in non-metastatic colon cancer

Log odds of positive lymph nodes is prognostically equivalent to lymph node ratio in non-metastatic colon cancer
10    50    0
Capecitabine in the routine first-line treatment of elderly patients with advanced colorectal cancer - results from a non-interventional observation study

Capecitabine in the routine first-line treatment of elderly patients with advanced colorectal cancer - results from a non-interventional observation study
9    51    0
Primary tumor site is a useful predictor of cetuximab efficacy in the third-line or salvage treatment of KRAS wild-type (exon 2 non-mutant) metastatic colorectal cancer: A nationwide cohort study

Primary tumor site is a useful predictor of cetuximab efficacy in the third-line or salvage treatment of KRAS wild-type (exon 2 non-mutant) metastatic colorectal cancer: A nationwide cohort study
8    53    0
SNAI2/SLUG and estrogen receptor mRNA expression are inversely correlated and prognostic of patient outcome in metastatic non-small cell lung cancer

SNAI2/SLUG and estrogen receptor mRNA expression are inversely correlated and prognostic of patient outcome in metastatic non-small cell lung cancer
7    63    0
Treatment response lowers tumor symptom burden in recurrent and/or metastatic head and neck cancer

Treatment response lowers tumor symptom burden in recurrent and/or metastatic head and neck cancer
11    88    0
Comparison of survival in non-metastatic inflammatory and other T4 breast cancers: A SEER population-based analysis

Comparison of survival in non-metastatic inflammatory and other T4 breast cancers: A SEER population-based analysis
7    41    1
A high CD8 to FOXP3 ratio in the tumor stroma and expression of PTEN in tumor cells are associated with improved survival in non-metastatic triple-negative breast carcinoma

A high CD8 to FOXP3 ratio in the tumor stroma and expression of PTEN in tumor cells are associated with improved survival in non-metastatic triple-negative breast carcinoma
12    133    1
Utility of kynurenic acid for non invasive detection of metastatic spread to lymph nodes in non small cell lung cancer

Utility of kynurenic acid for non invasive detection of metastatic spread to lymph nodes in non small cell lung cancer
8    44    0
An open-label expanded access program of afatinib in EGFR tyrosine kinase inhibitornaïve patients with locally advanced or metastatic non-small cell lung cancer harboring EGFR mutations

An open-label expanded access program of afatinib in EGFR tyrosine kinase inhibitornaïve patients with locally advanced or metastatic non-small cell lung cancer harboring EGFR mutations
11    105    1
Metastatic non-muscle invasive bladder cancer with meningeal carcinomatosis: Case report of an unexpected response

Metastatic non-muscle invasive bladder cancer with meningeal carcinomatosis: Case report of an unexpected response
4    78    0
Results of antiandrogen and biphosphonate therapy in treatment of bone metastatic prostate cancer in 108 Military Central Hospital

Results of antiandrogen and biphosphonate therapy in treatment of bone metastatic prostate cancer in 108 Military Central Hospital
8    69    0
Comparative survival benefit of currently licensed second or third line treatments for epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) negative advanced or metastatic non-small cell lung cancer: A systematic review and secondary analysis of trials

Comparative survival benefit of currently licensed second or third line treatments for epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) negative advanced or metastatic non-small cell lung cancer: A systematic review and secondary analysis of trials
17    48    0
DNA methylation associates with survival in non-metastatic clear cell renal cell carcinoma

DNA methylation associates with survival in non-metastatic clear cell renal cell carcinoma
16    67    0
Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR: A multicentre, randomised controlled openlabel phase II trial

Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR: A multicentre, randomised controlled openlabel phase II trial
10    54    0
Iterative sorting reveals CD133+ and CD133- melanoma cells as phenotypically distinct populations

Iterative sorting reveals CD133+ and CD133- melanoma cells as phenotypically distinct populations
11    79    0
Genetic heterogeneity of actionable genes between primary and metastatic tumor in lung adenocarcinoma

Genetic heterogeneity of actionable genes between primary and metastatic tumor in lung adenocarcinoma
9    68    0
Stage and tissue-specific prognostic impact of miR-182 in NSCLC

Stage and tissue-specific prognostic impact of miR-182 in NSCLC
10    78    0
The surgical treatment of non-metastatic melanoma in a Clinical National Melanoma Registry Study Group (CNMR): A retrospective cohort quality improvement study to reduce the morbidity rates

The surgical treatment of non-metastatic melanoma in a Clinical National Melanoma Registry Study Group (CNMR): A retrospective cohort quality improvement study to reduce the morbidity rates
9    52    1
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.